ARCHIVES

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979

Clinical Trials Approved By NCI

September 26, 2003

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant.

April 16, 2004